Sikander Hayat

Sikander Hayat

Auto-generated profile, based on publicly available information

Sikander Hayat

Institute of Experimental Medicine and Systems Biology, RWTH Aachen University, Aachen, Germany

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 October 2024 in Nature
Verified
Journal Article
Closed access
PDF file
JAJunedh M. Amrute
Junedh M. Amrute
XLXin Luo
Xin Luo
VPVinay Penna
Vinay Penna
SYSteven Yang
Steven Yang
TYTracy Yamawaki
Tracy Yamawaki
KLKORY J. LAVINE
KORY J. LAVINE

18 September 2024 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
AKAteeq M. Khaliq
Ateeq M. Khaliq
MRMeenakshi Rajamohan
Meenakshi Rajamohan
OSOmer Saeed
Omer Saeed
KMKimia Mansouri
Kimia Mansouri
AAAsif Adil
Asif Adil
AMAshiq Masood
Ashiq Masood

23 December 2024 in Nature Cardiovascular Research
Verified
Journal Article
Closed access
PDF file
TBTore Bleckwehl
Tore Bleckwehl
ABAnne Babler
Anne Babler
MTMerel Tebens
Merel Tebens
SMSidrah Maryam
Sidrah Maryam
MNMichael Nyberg
Michael Nyberg
SHSikander Hayat
Sikander Hayat

1 June 2023 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
CAChristina Alter
Christina Alter
AHAnne-Sophie Henseler
Anne-Sophie Henseler
COChristoph Owenier
Christoph Owenier
JHJulia Hesse
Julia Hesse
DZDing Zhaoping
Ding Zhaoping
JSJürgen Schrader
Jürgen Schrader
Plasma IL-6 is elevated after myocardial infarction (MI) and is associated with increased morbidity and mortality. Which cardiac cell type preferentially contributes to IL-6 expression and how its production is regulated are largely unknown. Here, we studied the cellular source and purinergic regulation of IL-6 formation in a murine MI model. We found that IL-6, measured in various cell types in post-MI hearts at the protein level and by quantitative PCR and RNAscope, was preferentially formed by cardiac fibroblasts (CFs). Single-cell RNA-Seq (scRNA-Seq) in infarcted mouse and human hearts confirmed this finding. We found that adenosine stimulated fibroblast IL-6 formation via the adenosine receptor A2bR in a Gq-dependent manner. CFs highly expressed Adora2b and rapidly degraded extracellular ATP to AMP but lacked CD73. In mice and humans, scRNA-Seq revealed that Adora2B was also mainly expressed by fibroblasts. We assessed global IL-6 production in isolated hearts from mice lacking CD73 on T cells (CD4-CD73–/–), a condition known to be associated with adverse cardiac remodeling. The ischemia-induced release of IL-6 was strongly attenuated in CD4-CD73–/– mice, suggesting adenosine-mediated modulation. Together, these findings demonstrate that post-MI IL-6 was mainly derived from activated CFs and was controlled by T cell–derived adenosine. We show that purinergic metabolic cooperation between CFs and T cells is a mechanism that modulates IL-6 formation by the heart and has therapeutic potential.

27 October 2022 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
YXYaoxian Xu
Yaoxian Xu
CKChristoph Kuppe
Christoph Kuppe
JPJavier Perales-Patón
Javier Perales-Patón
SHSikander Hayat
Sikander Hayat
JKJennifer Kranz
Jennifer Kranz
RKRafael Kramann
Rafael Kramann

8 August 2024 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
KHKonrad Hoeft
Konrad Hoeft
LKLars Koch
Lars Koch
SZSusanne Ziegler
Susanne Ziegler
LZLing Zhang
Ling Zhang
SLSteffen Luetke
Steffen Luetke
RKRafael Kramann
Rafael Kramann
Fibrosis represents the uncontrolled replacement of parenchymal tissue with extracellular matrix (ECM) produced by myofibroblasts. While genetic fate-tracing and single-cell RNA-Seq technologies have helped elucidate fibroblast heterogeneity and ontogeny beyond fibroblast to myofibroblast differentiation, newly identified fibroblast populations remain ill defined, with respect to both the molecular cues driving their differentiation and their subsequent role in fibrosis. Using an unbiased approach, we identified the metalloprotease ADAMTS12 as a fibroblast-specific gene that is strongly upregulated during active fibrogenesis in humans and mice. Functional in vivo KO studies in mice confirmed that Adamts12 was critical during fibrogenesis in both heart and kidney. Mechanistically, using a combination of spatial transcriptomics and expression of catalytically active or inactive ADAMTS12, we demonstrated that the active protease of ADAMTS12 shaped ECM composition and cleaved hemicentin 1 (HMCN1) to enable the activation and migration of a distinct injury-responsive fibroblast subset defined by aberrant high JAK/STAT signaling.